| - GRCh37:
- Chr2:152394381
- GRCh38:
- Chr2:151537867
| NEB | | Nemaline myopathy 2 | Uncertain significance (Jun 28, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152363484-152363485
- GRCh38:
- Chr2:151506970-151506971
| NEB, RIF1 | T6131fs, T7832fs, T7867fs | Nemaline myopathy 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:152487314
- GRCh38:
- Chr2:151630800
| NEB | W2970*, W3213* | Nemaline myopathy 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:152527710
- GRCh38:
- Chr2:151671196
| NEB | K1445* | Nemaline myopathy 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:152483693
- GRCh38:
- Chr2:151627179
| NEB | W3147*, W3390* | Nemaline myopathy 2 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr2:152468698
- GRCh38:
- Chr2:151612184
| NEB | | Nemaline myopathy 2 | Uncertain significance (May 2, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152472595
- GRCh38:
- Chr2:151616081
| NEB | S3494F, S3737F | Nemaline myopathy 2 | Uncertain significance (May 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152370925
- GRCh38:
- Chr2:151514411
| RIF1, NEB | D5977E, D7678E, D7713E | Nemaline myopathy 2 | Uncertain significance (May 7, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152408343-152408353
- GRCh38:
- Chr2:151551829-151551839
| NEB | Y4914fs, Y6615fs | Nemaline myopathy 2 | Likely pathogenic (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152357910
- GRCh38:
- Chr2:151501396
| NEB, RIF1 | S8006G, S8041G | Nemaline myopathy 2 | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152468727
- GRCh38:
- Chr2:151612213
| NEB | | Nemaline myopathy 2 | Benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152342343
- GRCh38:
- Chr2:151485829
| RIF1, NEB | W6647*, W8503*, W8538* | Nemaline myopathy 2, not provided | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152394768
- GRCh38:
- Chr2:151538254
| NEB | | Nemaline myopathy 2 | Likely benign (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152406218
- GRCh38:
- Chr2:151549704
| NEB | G4960R, G6661R | Nemaline myopathy 2 | Likely benign (Oct 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152522833
- GRCh38:
- Chr2:151666319
| NEB | H1601R | Nemaline myopathy 2 | Uncertain significance (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152499078-152500653
| NEB | | Nemaline myopathy 2 | Pathogenic (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152470770-152554182
| NEB | | Nemaline myopathy 2 | Pathogenic (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152417187-152418727
| NEB | | Nemaline myopathy 2 | Pathogenic (Nov 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152466303-152477560
| NEB | | Nemaline myopathy 2 | Uncertain significance (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152348187-152425896
| NEB | | Nemaline myopathy 2 | Likely pathogenic (Sep 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152506680-152510623
| NEB | | Nemaline myopathy 2 | Pathogenic (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152579876-152589670
| NEB | | Nemaline myopathy 2 | Pathogenic (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152369227-152376302
| NEB | | Nemaline myopathy 2 | Uncertain significance (Dec 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152466303-152563531
| NEB | | Nemaline myopathy 2 | Pathogenic (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152482028-152566297
| NEB | | Nemaline myopathy 2 | Pathogenic (Nov 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152408232-152432888
| NEB | | Nemaline myopathy 2 | Pathogenic (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152466303-152955525
| CACNB4, ARL5A, NEB | | Nemaline myopathy 2 | Pathogenic (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152470770-152471121
| NEB | | Nemaline myopathy 2 | Uncertain significance (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152475955-152476286
| NEB | | Nemaline myopathy 2 | Pathogenic (Mar 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152387634
- GRCh38:
- Chr2:151531120
| RIF1, NEB | | Nemaline myopathy 2 | Likely benign (Dec 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152492804
- GRCh38:
- Chr2:151636290
| NEB | | Nemaline myopathy 2 | Likely benign (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152518775
- GRCh38:
- Chr2:151662261
| NEB | | Nemaline myopathy 2 | Likely benign (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152456982
- GRCh38:
- Chr2:151600468
| NEB | | Nemaline myopathy 2 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152354238-152354239
- GRCh38:
- Chr2:151497724-151497725
| NEB, RIF1 | | Nemaline myopathy 2 | Uncertain significance (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152370077
- GRCh38:
- Chr2:151513563
| RIF1, NEB | | Nemaline myopathy 2 | Likely benign (Jan 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152459122
- GRCh38:
- Chr2:151602608
| NEB | | Nemaline myopathy 2 | Likely benign (Jan 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152346607
- GRCh38:
- Chr2:151490093
| RIF1, NEB | | Nemaline myopathy 2 | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152420399
- GRCh38:
- Chr2:151563885
| NEB | T4472P, T6173P | Nemaline myopathy 2 | Uncertain significance (Sep 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152539235
- GRCh38:
- Chr2:151682721
| NEB | V962M | Nemaline myopathy 2 | Likely benign (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152398083
- GRCh38:
- Chr2:151541569
| NEB | | Nemaline myopathy 2 | Uncertain significance (Aug 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152507239
- GRCh38:
- Chr2:151650725
| NEB | S2359T | Nemaline myopathy 2 | Likely benign (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152371408
- GRCh38:
- Chr2:151514894
| RIF1, NEB | K5946R, K7647R, K7682R | Nemaline myopathy 2 | Likely benign (Nov 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152499862
- GRCh38:
- Chr2:151643348
| NEB | L2654F | not provided, Nemaline myopathy 2 | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152346971
- GRCh38:
- Chr2:151490457
| NEB, RIF1 | | Nemaline myopathy 2 | Benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152406155
- GRCh38:
- Chr2:151549641
| NEB | S4981G, S6682G | Nemaline myopathy 2 | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152512493
- GRCh38:
- Chr2:151655979
| NEB | | Nemaline myopathy 2 | Likely benign (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152465119
- GRCh38:
- Chr2:151608605
| NEB | | Nemaline myopathy 2 | Likely benign (Nov 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152566189
- GRCh38:
- Chr2:151709675
| NEB | A339V | Nemaline myopathy 2 | Uncertain significance (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152383517
- GRCh38:
- Chr2:151527003
| NEB, RIF1 | R5586Q, R7287Q, R7322Q | Nemaline myopathy 2 | Likely benign (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152346471
- GRCh38:
- Chr2:151489957
| NEB, RIF1 | | Nemaline myopathy 2 | Likely benign (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152423732
- GRCh38:
- Chr2:151567218
| NEB | D4335H, D6036H | Nemaline myopathy 2 | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152518732
- GRCh38:
- Chr2:151662218
| NEB | H1963Y | Nemaline myopathy 2 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152348947
- GRCh38:
- Chr2:151492433
| RIF1, NEB | T6420N, T8276N, T8311N | Nemaline myopathy 2 | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152457244
- GRCh38:
- Chr2:151600730
| NEB | | Nemaline myopathy 2 | Likely benign (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152586135
- GRCh38:
- Chr2:151729621
| NEB | | Nemaline myopathy 2 | Likely benign (Jun 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152370854
- GRCh38:
- Chr2:151514340
| RIF1, NEB | N6001S, N7702S, N7737S | Nemaline myopathy 2 | Likely benign (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152404846
- GRCh38:
- Chr2:151548332
| NEB | | Nemaline myopathy 2 | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152502657
- GRCh38:
- Chr2:151646143
| NEB | I2508T | Nemaline myopathy 2 | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152346503
- GRCh38:
- Chr2:151489989
| NEB, RIF1 | | Nemaline myopathy 2 | Likely benign (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152541418
- GRCh38:
- Chr2:151684904
| NEB | | Nemaline myopathy 2 | Likely benign (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152534483
- GRCh38:
- Chr2:151677969
| NEB | N1158K | Nemaline myopathy 2 | Uncertain significance (Aug 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152426856
- GRCh38:
- Chr2:151570342
| NEB | | Nemaline myopathy 2 | Likely benign (Apr 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152370162
- GRCh38:
- Chr2:151513648
| RIF1, NEB | L6024V, L7725V, L7760V | Nemaline myopathy 2 | Likely benign (Mar 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152553672
- GRCh38:
- Chr2:151697158
| NEB | Q487L | Nemaline myopathy 2 | Likely benign (May 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152382541
- GRCh38:
- Chr2:151526027
| NEB, RIF1 | | Nemaline myopathy 2 | Likely benign (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152534237
- GRCh38:
- Chr2:151677723
| NEB | I1206V | Nemaline myopathy 2 | Uncertain significance (Aug 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152574014
- GRCh38:
- Chr2:151717500
| NEB | | Nemaline myopathy 2 | Likely benign (Oct 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152461218
- GRCh38:
- Chr2:151604704
| NEB | | Nemaline myopathy 2 | Likely benign (Oct 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152467079
- GRCh38:
- Chr2:151610565
| NEB | D3747A, D3990A | Nemaline myopathy 2 | Likely pathogenic (Jan 20, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr2:152496563
- GRCh38:
- Chr2:151640049
| NEB | K2899fs | Nemaline myopathy 2 | Likely pathogenic (Jan 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152397279
- GRCh38:
- Chr2:151540765
| NEB | H5206fs, H6907fs | Nemaline myopathy 2 | Pathogenic (Jan 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152404857
- GRCh38:
- Chr2:151548343
| NEB | V6708I, V5007I | Nemaline myopathy 2 | Uncertain significance (Jan 25, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152499734
- GRCh38:
- Chr2:151643220
| NEB | F2697S | Inborn genetic diseases, Nemaline myopathy 2 | Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152521899
- GRCh38:
- Chr2:151665385
| NEB | M1729T | Nemaline myopathy 2 | Likely benign (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152548824
- GRCh38:
- Chr2:151692310
| NEB | C650Y | Nemaline myopathy 2 | Uncertain significance (May 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152487787
- GRCh38:
- Chr2:151631273
| NEB | K3163R | not provided, Nemaline myopathy 2 | Uncertain significance (Jul 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152531863
- GRCh38:
- Chr2:151675349
| NEB | T1273A | not provided, Nemaline myopathy 2 | Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152404157
- GRCh38:
- Chr2:151547643
| NEB | V5051fs, V6752fs | Nemaline myopathy 2 | Pathogenic (May 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152394723
- GRCh38:
- Chr2:151538209
| NEB | | Nemaline myopathy 2 | Uncertain significance (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152346955
- GRCh38:
- Chr2:151490441
| RIF1, NEB | E8410K, E8445K, E6554K | Nemaline myopathy 2 | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152342287
- GRCh38:
- Chr2:151485773
| RIF1, NEB | V8557A, V6666A, V8522A | Nemaline myopathy 2, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Feb 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152553238
- GRCh38:
- Chr2:151696724
| NEB | K494N | Nemaline myopathy 2 | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152528997
- GRCh38:
- Chr2:151672483
| NEB | M1395I | Nemaline myopathy 2, not provided | Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152492766
- GRCh38:
- Chr2:151636252
| NEB | K3026R | Nemaline myopathy 2, not provided | Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:152403945
- GRCh38:
- Chr2:151547431
| NEB | D5088N, D6789N | Nemaline myopathy 2, not provided | Conflicting interpretations of pathogenicity (Oct 18, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152349856
- GRCh38:
- Chr2:151493342
| RIF1, NEB | | Nemaline myopathy 2 | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152487733
- GRCh38:
- Chr2:151631219
| NEB | D3181G | Nemaline myopathy 2 | Uncertain significance (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152554055
- GRCh38:
- Chr2:151697541
| NEB | | Nemaline myopathy 2 | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152382499
- GRCh38:
- Chr2:151525985
| NEB, RIF1 | | Nemaline myopathy 2 | Benign (Apr 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152527659
- GRCh38:
- Chr2:151671145
| NEB | K1462E | Nemaline myopathy 2, not provided | Conflicting interpretations of pathogenicity (May 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152474884
- GRCh38:
- Chr2:151618370
| NEB | I3661F, I3418F | Nemaline myopathy 2 | Likely benign (May 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152512320
- GRCh38:
- Chr2:151655806
| NEB | | Nemaline myopathy 2 | Likely benign (Jan 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152544837
- GRCh38:
- Chr2:151688323
| NEB | Q795R | Nemaline myopathy 2 | Uncertain significance (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152563380
- GRCh38:
- Chr2:151706866
| NEB | | Nemaline myopathy 2 | Uncertain significance (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152566265
- GRCh38:
- Chr2:151709751
| NEB | E314K | Nemaline myopathy 2 | Likely benign (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152511837
- GRCh38:
- Chr2:151655323
| NEB | P2252S | Nemaline myopathy 2, not provided | Conflicting interpretations of pathogenicity (Sep 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152390749
- GRCh38:
- Chr2:151534235
| RIF1, NEB | A5432T, A7133T | Inborn genetic diseases, Nemaline myopathy 2 | Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr2:152484136
- GRCh38:
- Chr2:151627622
| NEB | | Nemaline myopathy 2 | Likely benign (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152404896
- GRCh38:
- Chr2:151548382
| NEB | A4994P, A6695P | Nemaline myopathy 2 | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:152520319
- GRCh38:
- Chr2:151663805
| NEB | S1836G | Nemaline myopathy 2 | Likely benign (Sep 14, 2022) | criteria provided, single submitter |